- Home
- KYMR vs CALX Comparison
KYMR vs CALX Comparison
Compare KYMR & CALX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- CALX
- Stock Information
- Founded
- KYMR 2015
- CALX 1999
- Country
- KYMR United States
- CALX United States
- Employees
- KYMR N/A
- CALX N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- CALX Telecommunications Equipment
- Sector
- KYMR Health Care
- CALX Consumer Discretionary
- Exchange
- KYMR Nasdaq
- CALX Nasdaq
- Market Cap
- KYMR 4.2B
- CALX 4.2B
- IPO Year
- KYMR 2020
- CALX 2010
- Fundamental
- Price
- KYMR $56.83
- CALX $59.34
- Analyst Decision
- KYMR Strong Buy
- CALX Strong Buy
- Analyst Count
- KYMR 17
- CALX 5
- Target Price
- KYMR $61.65
- CALX $64.00
- AVG Volume (30 Days)
- KYMR 910.5K
- CALX 520.5K
- Earning Date
- KYMR 10-30-2025
- CALX 10-29-2025
- Dividend Yield
- KYMR N/A
- CALX N/A
- EPS Growth
- KYMR N/A
- CALX N/A
- EPS
- KYMR N/A
- CALX N/A
- Revenue
- KYMR $44,711,000.00
- CALX $869,193,000.00
- Revenue This Year
- KYMR $62.11
- CALX $17.57
- Revenue Next Year
- KYMR N/A
- CALX $10.16
- P/E Ratio
- KYMR N/A
- CALX N/A
- Revenue Growth
- KYMR N/A
- CALX N/A
- 52 Week Low
- KYMR $19.45
- CALX $28.61
- 52 Week High
- KYMR $59.00
- CALX $64.30
- Technical
- Relative Strength Index (RSI)
- KYMR 65.68
- CALX 43.80
- Support Level
- KYMR $54.09
- CALX $58.82
- Resistance Level
- KYMR $59.00
- CALX $61.79
- Average True Range (ATR)
- KYMR 2.39
- CALX 1.53
- MACD
- KYMR 0.30
- CALX -0.51
- Stochastic Oscillator
- KYMR 80.00
- CALX 2.19
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About CALX Calix Inc
Calix Inc develops, markets and sells its appliance-based platform, cloud and managed services that enable service providers of all types and sizes to innovate and transform their businesses. The company's customers utilize the real-time data and insights from Calix platforms to simplify their business and deliver experiences that excite their subscribers. The resulting growth in subscriber acquisition, loyalty and revenue creates more value for their businesses and communities. The Company's revenue is principally derived in the United States and it also has its presence in Middle East & Africa, Europe, Asia Pacific and other markets.